Report cover image

Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Jan 30, 2023
Length 86 Pages
SKU # LPI17685220

Description

Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2023-2029

According to this study, the global Nucleic Acid Drugs market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.

Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other

Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

86 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Nucleic Acid Drugs Key Players
4 Nucleic Acid Drugs by Regions
5 United States
6 Europe
7 China
8 Rest of World
9 Market Drivers, Challenges and Trends
10 Key Investors in Nucleic Acid Drugs
11 Key Players Analysis
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us